• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Why patient centricity is the answer to the clinical trial enrolment gap  - Pharmaceutical Technology - 2 year(s) ago

      Research indicates that designing clinical trials with the patient in mind reduces recruitment times and enhances trial performance.

      Source: www.pharmaceutical-technology.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	TWDigitalHealth
        TWDigitalHealth

        Why patient centricity is the answer to the clinical trial enrolment gap  - Pharmaceutical Technology https://t.co/PwhnRSVyR8 https://t.co/fwCKdIMz79

    • Mashup Score: 7
      CAR-T therapies and cancer risk: No easy answers for the FDA - 2 year(s) ago

      CAR-T cell therapies can provide durable cancer remission, however, a recent FDA investigation into reports of secondary T-cell malignancies has increased scrutiny of their risk profiles.

      Source: www.pharmaceutical-technology.com
      Categories: General Medicine News, Partners & KOLs
      Tweet Tweets with this article
      • Profile photo of 	RahulBanerjeeMD
        RahulBanerjeeMD

        RT @BLLPHD: This link works https://t.co/pUR4HPtWEA

    • Mashup Score: 0
      Memo Therapeutics raises $27.67m for kidney transplant infection trial - Pharmaceutical Technology - 2 year(s) ago

      Memo’s fast track-designated candidate is currently in a Phase II trial for BKV infection, with a data readout expected in 2024.

      Source: www.pharmaceutical-technology.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	TWDigitalHealth
        TWDigitalHealth

        Memo Therapeutics raises $27.67m for kidney transplant infection trial - Pharmaceutical Technology https://t.co/B2hMY6cBN7 https://t.co/Xr7wY70g7C

    • Mashup Score: 0
      ONL Therapeutics seeks upto $100m to further eye disease pipeline - Pharmaceutical Technology - 2 year(s) ago

      ONL Therapeutics plans to raise $75-$100m to support Phase II trials in geographic atrophy and open-angle glaucoma.

      Source: www.pharmaceutical-technology.com
      Categories: General Medicine News, Future of Medicine
      Tweet Tweets with this article
      • Profile photo of 	TWDigitalHealth
        TWDigitalHealth

        ONL Therapeutics plans to raise $75-$100m to support Phase II trials in geographic atrophy and open-angle glaucoma. https://t.co/NfFFZN9rdN https://t.co/SE12GLOM3r

    • Mashup Score: 1
      Roche wins first approval for subcutaneous Tecentriq - Pharmaceutical Technology - 2 year(s) ago

      The subcutaneous Tecentriq has been approved in the UK for all indications that its intravenous counterpart has received approval.

      Source: www.pharmaceutical-technology.com
      Categories: Cardiologists, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	afshineemrani
        afshineemrani

        Roche wins first approval for subcutaneous Tecentriq. Amazing. Not IV. An anticancer shot. 👏 https://t.co/nDCwKAwet0 via @PharmaTechFocus

    • Mashup Score: 2
      Artificial intelligence is set to power the future of healthcare provision - Pharmaceutical Technology - 2 year(s) ago

      An increasing amount of information make artificial intelligence (AI) stand out as a promising solution to improve the provision of healthcare.

      Source: www.pharmaceutical-technology.com
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	EvanKirstel
        EvanKirstel

        Artificial intelligence is set to power the future of healthcare provision https://t.co/bEfu79FVyD https://t.co/RQxf0peYwZ

    • Mashup Score: 3
      Healthtech trends: Digital Health leads Twitter mentions in Q3 2021 - 4 year(s) ago

      Pharmaceutical Technology lists the top five terms tweeted on healthtech in Q3 2021, based on GlobalData’s Healthcare Influencer Platform.

      Source: www.pharmaceutical-technology.com
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	HealthcareLdr
        HealthcareLdr

        #Healthtech trends: #DigitalHealth leads Twitter mentions in Q3 2021 https://t.co/HJbYV1BqHG #wearabletech #mhealth #AI #ML #Pharmaceutical cc @IanLJones98 @daniel_kraft https://t.co/zBjrNypnq8

    • Mashup Score: 2
      Antibiotic resistance: how AI can tackle the superbug threat - 4 year(s) ago

      Researchers are employing innovative AI methods to combat the growing global threat of antibiotic resistance.

      Source: www.pharmaceutical-technology.com
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	Berci
        Berci

        In a recent, IBM-led study, researchers developed a generative A.I. model to accelerate the discovery of broad-spectrum, low-toxicity and low-resistance antimicrobial peptides. Maybe this seems to be a better A.I. path forward for IBM instead of Watson. https://t.co/HTK4A1Exc1

    • Mashup Score: 13
      Antibiotic resistance: how AI can tackle the superbug threat - 4 year(s) ago

      Researchers are employing innovative AI methods to combat the growing global threat of antibiotic resistance.

      Source: www.pharmaceutical-technology.com
      Categories: Future of Medicine, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	ahier
        ahier

        RT @SpirosMargaris: Antibiotic #resistance: how #AI can tackle the #superbug #threat https://t.co/xxSi84Eppf #fintech #insurtech #insur…

    • Mashup Score: 112
      Twitter round-up: Peter Hotez’s tweet on Covid-19 shots for Americans amid soaring infections top tweet in Q3 2021 - 4 year(s) ago

      Pharmaceutical Technology lists five of the top tweets on infectious diseases in Q3 2021 based on data from GlobalData’s Influencer Platform.

      Source: www.pharmaceutical-technology.com
      Categories: Healthcare Professionals, Latest Headlines
      Tweet Tweets with this article
      • Profile photo of 	PeterHotez
        PeterHotez

        Wow, they rank everything these days, even tweets. Thanks for making me number one! https://t.co/cHjDQfcRsy

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings